Laxai Pharma, Ltd.

$0.00+0.00%(+$0.00)
TickerSpark Score

Not enough financial coverage to compute a composite score for LAXAF. This is typical for foreign-listed ADRs, recent IPOs, or thinly-covered small caps. Live quote, chart, and any available data still render below.

Momentum30
52-Week Range50% of range
Low $0.00
Current $0.00
High $0.00

Company

Laxai Pharma, Ltd. offers contract research services in the United States. It provides integrated services across the drug development spectrum.

CEO
J. Ram Ajjarapu
IPO
1994
Employees
1
HQ
Tampa, FL, US

Price Chart

-98.00% · this period
$0.01$0.00$0.00May 23Nov 21May 23

Performance & Tape

52W High
$0.00
52W Low
$0.00
50D MA
$0.00
200D MA
$0.00
Beta
2.45
Avg Volume
3

Get TickerSpark's AI analysis on LAXAF

Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.

Get Pro Access →

30-day money-back guarantee · cancel anytime

Recent Insider Transactions

DateInsiderTypeShares
Feb 18, 11UTA Capital LLCother16,800,000
Jul 1, 10UTA Capital LLCother7,820,000

Our LAXAF Coverage

We haven't published any research on LAXAF yet

For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.

Generate LAXAF Report →

Similar Companies